Chromosomal translocations involving the MYC oncogene are a hallmark of Burkitt lymphoma but they are only found in a varying frequency in mature Burkitt-type acute lymphoblastic leukemia (B-ALL). We have investigated samples of 56 sporadic Burkitt leukemia/lymphoma patients for the translocations t(8;14)(q24;q32), t(2;8)(p11;q24) and t(8;22)(q24;q11). Long PCR was used for detecting the immunoglobulin heavy chain (IgH) translocation and cytogenetics and/or fluorescence in situ hybridization for detecting the 'variant' MYC translocations. A total of 29 samples (51.8%) were t(8;14)-positive by long PCR. Approximately one-third had a chromosomal breakpoint in the IgH joining region while the others had breakpoints in the IgH switch regions. Among them were two cases with a previously unreported MYC translocation into the IgE switch region. Long PCR was more reliable compared to conventional cytogenetics for detecting the t(8;14). Epstein-Barr virus was detected in high copy number in two (3.6%) t(8;14)-positive cases by realtime quantitative PCR. Human herpesvirus 8 was not detected in any case by nested PCR. A typical L3 or L3-compatible cytomorphology was highly predictive (480%) but not specific of a MYC translocation. A total of 34 patients were treated according to the GMALL B-ALL therapy protocols and there was no significant difference in overall survival between patients with or without t(8;14).
Introduction
The diagnosis of Burkitt-type acute lymphoblastic leukemia (B-ALL) is usually based on a combination of several diagnostic features. 1, 2 First, the immunophenotype of the blasts typically shows the expression of pan-and mature B-cell antigens (HLA-DR, CD19, cyCD22, CD79a) together with monoclonal surface immunoglobulin. Second, genetic analysis typically reveals chromosomal rearrangements affecting the locus of the MYC proto-oncogene on 8q24. MYC is most frequently found to be translocated into the immunoglobulin heavy chain (IgH) locus (t(8;14)(q24;q32)), whereas the less frequently observed variant translocations t(2;8)(p11;q24) and t(8;22)(q24;q11) juxtapose MYC to the light chain kappa (IgK) or lambda (IgL) locus, respectively. 3, 4 Third, B-ALL usually displays a typical cytomorphologic picture (L3 morphology according to FAB classification 5 ). However, clinical experience has shown that there are often discrepancies between morphology, immunophenotype and genotype. In particular, it is often difficult to distinguish B-ALL from leukemic follicular lymphoma by immunophenotypic flow cytometry. B-ALL cases with atypical non-L3 morphology and an otherwise typical genotype and immunophenotype have repeatedly been reported. Also cases with a not fully B-ALLtypical immunophenotype despite a MYC translocation have been observed. 6, 7 In adult cases, cytogenetic analysis sometimes does not reveal a MYC translocation despite a typical B-ALL immunophenotype and L3 morphology. It is also not clear up to what extent a MYC translocation correlates with a typical L3 morphology. Last but not least the prognostic relevance of chromosomal translocations involving MYC is unknown.
To address these questions, we have investigated 56 archived samples from patients with the immunophenotypic diagnosis of mature B-ALL (N ¼ 51) or Burkitt or Burkitt-like lymphoma (N ¼ 5) using long PCR for the presence of the translocation t(8;14)(q24;q11). In 46 cases, additional cytogenetic and/or fluorescence in situ hybridization (FISH) data were available. We also compared the immunophenotype and the morphology in a respective diagnostic reference center with the genetic findings and assessed the prognostic implications of the genetic findings.
Materials

Patient material
Bone marrow, peripheral blood or ascites samples were sent to the central reference laboratory of the GMALL study group (Medizinische Klinik III, Charité CBF, Berlin) for immunophenotypic analysis. In addition, cytomorphologic investigation of smear preparations was carried out at the GMALL reference center for cytomorphology (Medizinische Klinik II, UKSH, Campus Kiel). The samples were obtained between 1988 and 2002. A total of 56 stored samples (peripheral blood ¼ 16, bone marrow ¼ 38, ascites ¼ 2) were available for further molecular analysis. Three samples had been taken at the time of relapse and 53 were obtained at the time of primary diagnosis without previous treatment.
Immunophenotyping
Immunophenotyping of fresh samples was performed at the central reference laboratory for immunologic analysis of the GMALL study group at the Charité CBF Berlin using standard procedures as described previously. 8 Samples were analyzed by applying commercially available fluorochrome-labelled monoclonal antibodies and by using a FACScan and Cell Quest software (Becton Dickinson, Heidelberg, Germany). Cell surface antigens were considered positive when 20% or more cells had a fluorescence intensity greater than negative control specimens. The threshold for positivity in intracytoplasmic/intranuclear stainings (eg TdT) was 10%. Samples were classified as Burkitt-type leukemia/lymphoma when expressing pan/mature B-cell antigens (eg CD19, CD20), surface immunoglobulin (sIg) and CD10 without TdT or antigens suggesting an alternative diagnosis (eg CD23, coexpression of CD5). An atypical immunophenotype was considered possible in cases with CD10À, sIgÀ or TdT þ.
Cytomorphology
Morphologic investigation of samples was carried out at the central reference laboratory for cytomorphology of the GMALL study group at Kiel University (HA Horst). Smear preparations were evaluable in 48 cases (89%). The samples were analyzed in a blinded fashion. Burkitt-type leukemia/lymphoma usually consists of cells with the characteristic L3 phenotype according to the FAB classification. 5 Cells with L3 morphology are medium sized to large and have a homogeneous appearance. The nucleus is round to oval and shows a dense but finely stippled chromatic pattern. Nucleoli are often present. The cytoplasm is moderately abundant and intensely basophilic. It characteristically contains medium-sized vacuoles. The samples were scored according to the following criteria: 3 ¼ typical L3 morphology, 2 ¼ compatible with L3 morphology (however, a characteristic feature is missing, for example, heterogeneous morphology or vacuoles missing), 1 ¼ criteria for L3 morphology are not met.
Cell lines
DNA was prepared from the following cell lines: CA-46, 9 Raji, 10 DG-75, 11 Ramos, 12 BCP-1. 13 The first three cell lines were obtained from the DSMZ Braunschweig/Germany (accession nos. 73, 319 and 83, respectively) and the last two were from the ATCC (accession nos. CRL-1596 and CRL-2294, respectively).
DNA preparation
DNA was prepared from isolated mononuclear cells, using an alkaline-lysis-based method with subsequent isopropanol precipitation (Puregene, Biozym Diagnostik, Hessisch Oldendorf/ Germany). DNA was dissolved in Tris/EDTA buffer at a photometrically determined concentration (GeneQuant II DNA/RNA calculator, Pharmacia) of 100 ng/ml.
Long PCR for detecting t(8;14)
Primer sequences of Myc/04 ACAGTCCTGGATGAT GATGTTTTTGATGAAGGTCT, Cm-1 TGCTGCTGATGTCAGA GTTGTTCTTGTATTTCCAG, Cg-1 GGTCACCACGCTGCTGAG GGAGTAGAGT and Ca-1 TCGTGTAGTGCTTCACGTGGCATG TCACGGACTTG are modifications of those published previously by Akasaka et al 14 and Basso et al. 15 Primer Ce-3 ATCGTGGGCGACTTGCGGATGAAC has been developed in this study. The JH consensus primer ACCTGAGGAGACGGT GACCAGGGT was first described by Crescenzi et al. 16 Primers were obtained from Metabion Inc. (Martinsried/Germany) and HPLC-purified. PCR was performed in a Perkin Elmer 9600 cycler using the Expand 20 kB PLUS system kit (Roche Biochemicals, Germany) with a 50 ml reaction mix with 600 nM primers and 500 mM dNTPs as well as a polymerase mix containing a mixture of Taq polymerase and proofreading Pwo polymerase. Buffer conditions followed the recommendations of the supplier. A 350 ng portion of genomic DNA sample was used in each PCR. A positive control (cell line DNA, see above) was included in every PCR. Cycling conditions were as follows: denaturation at 921C for 2 min, 15 cycles for 20 s at 921C, annealing at 621C for 30 s, and extension for 18 min at 681C, 20 additional cycles as described but with a 10 s increment per cycle in extension time, a 7-min final extension at 681C, and cooling to 41C. Aliquots of the PCR mixture were analyzed on a 1% agarose gel, electrophoretically separated in Tris/acetate/EDTA buffer and visualized under UV illumination after ethidium bromide staining. DNA integrity was ensured by subjecting each sample to a control PCR (primers HbG forw CACAAGGGCTACTGGT TGCCGATT and HbG rev AGCTTCCCAACGTGATCGCCTTT CTCCCAT) yielding a 28.8 kb amplification product. Samples that did not meet this standard were excluded from the investigation. All samples were investigated with five long PCRs for the MYC/IgH fusion. Each long PCR contained primer Myc/04 in combination with either Cg-1, Cm-1, Ce-3, Ca-1 or JH. The first four primers annealed in the constant gene regions of IgG1-4, IgM, IgE and IgA1-2, respectively. Primers Cg-1 and Ca-1 annealed in a region that is conserved between the constant genes of IgG1 and 4 and IgA1 and 2, respectively. Primer JH annealed at the 3 0 end of the joining (J) segments, a region that is conserved between IgH J1 and 6. The sensitivity of the long PCRs was evaluated by using serial dilutions of the cell lines Raji, Ramos, DG-75 and CA-46 in buffy coat leukocytes and turned out to be 10
À3
.
EBV nested PCR
Epstein-Barr virus (EBV) DNA was detected by nested PCR using the Taq PCR Master Mix kit (QIAGEN, Hilden/Germany). EBV primers were adopted from Cinque et al 17 (EB-2 modified: ACTCAATGGTGTAAGACGACAT). A 100 ng portion of DNA was used in the first PCR with 200 nM primers EB-1 and EB-2. A 1 ml portion from the first PCR was used in the second PCR with 200 nM primers EB-3 and EB-4. Cycling conditions were as follows: 2 min initial denaturation at 951C, 30 cycles of 30 s at 951C, 30 s at 531C (first PCR) or 571C (second PCR), 30 s at 721C, and a final elongation (5 min at 721C). A 100 pg portion of the EBV-infected cell line Raji served as positive control.
EBV quantitative real-time PCR
All EBV nested PCR-positive cases were further investigated by real-time PCR on an RG-3000 cycler (Corbett Research) using the RealArtt EBV RG PCR kit (Artus Inc., Hamburg/Germany) that allows an exact virus copy number quantification. DNA samples of 400 ng were used in every PCR.
HHV-8 nested PCR
The presence of HHV-8 was investigated by nested PCR using the same PCR conditions as described above for EBV except for the following modifications: primer pair KSHV-1 TCAGTGG GACAGCAACACCCAGCTAG, KSHV-2 AAGGTACATGGACA GATCGTCAAGC and annealing temperature 611C in the first 
Cytogenetic analysis
Chromosome banding analysis and fluorescence in situ hybridization on interphase nuclei (iFISH) were carried out essentially as described. 18 Commercially available probes located proximal and distal to MYC and labelled by distinct fluorochromes were used to uncover classical and variant 8q24 translocations by a separation of the signals (MYC break apart, Abbott, Germany). A cutoff rate for false positive nuclei was determined in PHAstimulated lymphoblasts of 10 healthy probands at 17.1% (mean, þ 2 Â standard deviation).
Results
Patients
The clinical characteristics of the 56 evaluable patients are summarized in Table 1 . The inclusion criteria were (1) a typical mature B-ALL immunophenotype (B-lineage antigens, surface immunoglobulin and CD10 positivity) with a morphology that had no features pointing to a mature, non-Burkitt-type B-cell lymphoma (eg mantle cell lymphoma) or (2) a typical L3 morphology with an immunophenotype compatible with mature B-ALL, that is, lack of expression of B-precursor ALL antigens (eg CD34).
Reliability of long PCR for the detection of t(8;14)(q24;q32)
A translocation of MYC into the IgH locus was detected in 29 cases (51.8%) by long PCR. The PCR product size varied from sample to sample, making false positive results due to contamination very unlikely (Figures 1a-e) . There was no single case with a translocation t (8;14) in the cytogenetic analysis without a corresponding positive t(8;14) long PCR result. In contrast, there were four t(8;14)-positive cases (5, 15, 26, 54) as revealed by long PCR without evidence of a MYC translocation in the cytogenetic analysis. The specificity of the PCR product was confirmed in every single case by sequencing the 3 0 and 5 0 ends of the PCR products using the PCR primers as sequencing primers (after PCR product purification). Since the PCR conditions allowed for the amplification of very long PCR products, some samples also yielded products with primers located in 3 0 downstream neighboring IgH constant regions. All (14) also showed a PCR product with a second PCR primer that was about 5-7 kb larger in size, corresponding to the genomic distance between the IgH J region and the adjacent constant gene region. In most cases, this was the IgM constant gene region (primer Cm-1; samples 3, 9, 10, 40, 49, 50). There were two JH PCR-positive samples that lacked a Cm-1 PCR product but showed a Ca-1 PCR product (sample 31) and a Cg-1 PCR product (sample 19) instead. These two cases were interpreted as resulting from a sample with a breakpoint in the JH region, which had undergone an isotype switch IgM-IgA and IgM-IgG, respectively. Sample 14 was JH-PCR-positive and Cm-1-PCR-positive. Both PCR products had approximately the same size and this was interpreted as a sample with two breakpoints (in the IgM switch region and in the joining region), resulting from a biallelic t(8;14) or biclonal t (8;14) . Samples 30 and 43 were positive with primer Ce-3 and also yielded a weak product with primer Ca-1. These Ca-1 PCR products were approximately 20 kb larger than the Ce-3 PCR product, thus resembling the genomic distance between the IgA2 and IgE constant region genes. One Cg-1-PCR-positive sample (44) also showed a weak product (420-25 kb) with primer Ce-3 (Figure 1e ), most likely explained by a chromosomal breakpoint in the IgG4 switch region that is located 23 kb 5 0 upstream of the IgE switch region (Figure 2 ). The distribution of chromosomal breakpoints is shown in Figure 2 .
Variant MYC translocations
Variant 8q24 translocations were either detected by conventional cytogenetics or by MYC-iFISH investigation. Cytogenetic data were available in 35 cases. A t(8;22) was detected in two cases, a t(2;8) in four cases, one sample showed a t(8;9)(q24;p21) and in another sample the translocation partner of MYC could not be identified (t(8;?)(q24;?)), but a t(8;14) was excluded by PCR. Four samples showed no t(8;14) by PCR but a MYC locus rearrangement by iFISH investigation suggestive of a variant 8q24 translocation.
Herpesviruses (EBV and HHV-8)
All samples were investigated for the presence of the two human oncogenic gamma herpesviruses EBV and human herpesvirus-8 (HHV-8). No sample was found to contain HHV-8. A sensitive nested PCR was used to screen for the presence of EBV. Positive samples were further investigated by real-time quantitative PCR. Only two samples (10, 50) showed a very high virus copy number (11 and 15 Â 10 6 virus copies/mg DNA) in accordance with copy numbers of 50-150 virus genomes/cell previously reported for Burkitt cell lines. 19 Both cases had a MYC translocation. There were some samples that had a copy number below 200 virus genomes/mg DNA. Since EBV is a nearly ubiquitous virus and small traces of various herpesviruses have been detected in diverse hematologic diseases, 20 these cases were regarded as EBV-negative.
Immunophenotypic analysis
Most of the patients showed a typical immunophenotype with expression of pan-and mature B-cell antigens. A total of 30 patients showed a light chain kappa and 22 a lambda restriction. Two samples (9, 40) appeared to be surface immunoglobulin polyclonal but showed an otherwise typical immunophenotype with compatible morphology and revealed a MYC/IgH fusion. The polyclonal pattern could possibly be explained by unspecific take-up of antibody by apoptotic cells in FACS analysis. Two samples (14, 44) even lacked surface immunoglobulin but showed an otherwise typical immunophenotype, an L3 morphology and a MYC/IgH fusion. TdT was positive in four cases. Three of them had a MYC translocation.
Morphology
A total of 48 patients had evaluable cytomorphologic data. The distribution of scores was as follows: 35 cases with score 3 (typical L3), eight cases with score 2 (compatible with L3) and Patients are listed in ascending order according to their age at diagnosis. Cytomorphologic classification was into three categories: 1: no L3 morphology; 2: compatible with L3 morphology; 3: typical L3 morphology. Some samples were not evaluable (NE) and others were not available (NA). Patient 14 showed a biallelic t(8;14) and patients 19 and 31 showed an isotype switch to the IgG and IgA switch region, respectively, after a MYC translocation to the joining region.
Molecular heterogeneity of Burkitt-type ALL T Burmeister et al compatible with an L3 morphology (score 2) while none showed an L3-incompatible morphology. There were at least five cases (7, 8, 16, 35, 46 ) with a typical L3 morphology without evidence of a MYC translocation (Table 2) .
Clinical features
A total of 34 patients were treated according to the GMALL study protocol B-ALL/B-NHL86 (N ¼ 3) or B-ALL/B-NHL90 (N ¼ 31) with or without study inclusion ( Table 1 ). The therapy details have been described previously (Hoelzer et al. Blood 2002; 100: 159 (abstract)). 21 The major difference between both protocols was the increase of methotrexate dose from 1.5 to 3.0 g/m 2 in study B-NHL90. No significant difference in overall survival and major clinical characteristics was observed between both groups (Figure 3) . The results of this study suggest that the MYC/IgH long PCR appears at least as suitable for the detection of the MYC/IgH translocation in sporadic Burkitt lymphoma/leukemia as the cytogenetic analysis. It even has some diagnostic advantages. It is more sensitive and does not require viable cells for analysis. It can be performed from peripheral blood or ascites samples where classical cytogenetics may fail because of lack of metaphases or low blast count. It also gives more detailed information on the chromosomal breakpoint, which can be used for minimal residual disease investigations. 24 However, since cytogenetic data were not available in all cases, larger comparative studies are needed to further evaluate these two diagnostic methods.
The REAL and WHO classification states that 'in endemic cases, the breakpoint on chromosome 14 involves the heavy chain joining region (early B cell), whereas in sporadic cases, the translocation involves the IgH switch region (later stage of B-cell)'. 1, 2 This contrasts with the results of our study, as is evident from the cases examined here, which are all sporadic cases. Both types of translocations can be found in sporadic Burkitttype acute leukemia or sporadic lymphoma -those involving the joining region and those involving the different constant gene switch regions. The distribution of chromosomal breakpoints in the IgH locus appears to reflect the different steps of B-cell maturation since the breakpoints in the joining region result from errors in VDJ recombination and the breakpoints in the switch regions result from errors in isotype switch recombination. Interestingly, the cellular isotype switch machinery is not turned off after a translocation of MYC to the IgH joining region and further isotype switch recombinations can occur as exemplified from the two cases found here that had undergone an isotype switch to IgG (19) and IgA (31), respectively, after the juxtaposition of MYC to the joining region. The distribution of breakpoints found in the present study is different from the patterns observed in sporadic BL using Southern blotting, where mainly IgA and IgM breakpoints were found. 25, 26 Interestingly, two cases of a previously unreported translocation of MYC in the IgE switch region were observed. Both cases presented with an atypical cytomorphology.
Another point of interest concerns the detection of EBV. As has been pointed out repeatedly, the role of EBV in sporadic lymphoma remains somewhat enigmatic. 27, 28 While 100% of endemic BL show the presence of EBV, only a minority of sporadic cases are associated with this virus. This study sheds some light on this topic. A total of 7% of t(8;14)-positive cases were EBV-positive, which is basically in accordance with previous reports. 25 In this context, it should be emphasized that the use of a conventional qualitative PCR may lead to overestimation of EBV positivity since this virus may be present in low copy number. 20 Therefore a quantitative PCR should be used for detecting EBV. Only cases with high virus copy number can be regarded as truly positive. HHV-8 is known to be etiologically involved in some malignant lymphoid diseases (body cavity based primary effusion lymphomas, multicentric Castleman's disease). 29 HHV-8 was not detected in any single case by nested PCR in accordance with previous reports. 29 The Figure 3 Survival according to t (8;14) . Clinical data of the 34 patients treated according to the GMALL B-ALL/NHL protocols according to t (8;14) . Three patients were treated according to the B-ALL/NHL86 protocol and the others according to the B-ALL/NHL90 protocol. A total of 31 patients had a Burkitt-type ALL and three a Burkitt-or Burkitt-like lymphoma.
negativity for HHV-8 excludes the differential diagnosis of primary effusion lymphoma, which may sometimes mimic the features of BL.
A trend toward clinical inferior outcome has recently been reported for patients with 8q24 aberrations compared to those without 8q24 aberrations. 30 The clinical course of the investigated patients in our series showed no significant differences in overall survival when treated according to the GMALL B-ALL/ NHL protocols (Figure 3) . However, one has to bear in mind that the t(8;14)-negative patient group includes the cases with variant MYC translocations.
In summary, we have described the genetic, cytomorphologic, immunologic and clinical features of a large cohort of sporadic B-ALL/BL patients. The genetic analysis revealed a marked heterogeneity and shed some additional light on the molecular fine structure of the MYC/IgH translocation in this disease category. The detection of a MYC translocation does not prove but confirms the diagnosis of mature B-ALL. Therefore, the most important conclusion drawn from our findings is the advice that genetic analysis in cases suspect of Burkitt lymphoma/ leukemia should also include a long PCR for t (8;14) in addition to conventional cytogenetics and FISH, particularly in cases where morphology and immunophenotype do not show typical findings.
